Leerink Partners Maintains Outperform on Progyny, Raises Price Target to $38
Benzinga Newsdesk 1 day ago
Analyst RatingsNewsPrice Target
Leerink Partners analyst Michael Cherny maintains Progyny (NASDAQ:PGNY) with a Outperform and raises the price target from $37 to $38.
Leerink Partners analyst Michael Cherny maintains Progyny (NASDAQ:PGNY) with a Outperform and raises the price target from $37 to $38.